Company Overview
Analiza is a US-based niche CRO that specializes in high-throughput physicochemical property and in-vitro ADME screening. By adapting, improving, and automating gold-standard methods for compatibility with early drug discovery, Analiza is able to deliver quality data with the fastest turnaround time, smallest sample requirements, and lowest costs in the industry.
Analiza works with pharma and biotech companies of all sizes to provide fast, accurate data. By choosing to operate as a non-GLP laboratory, Analiza is able to tailor every study to meet each client’s specific needs. Offering a variety of detection methods to measure molecular properties also makes Analiza the go-to CRO for projects with budgets of all sizes. Whether you need data for 1 compound or 1000, Analiza is able to help.
Since 1996, Analiza has pioneered unique technologies and solutions in four key areas:
- Automated analysis of physicochemical and pharmacokinetic (ADME) properties of small-molecule drug candidates
- Rapid characterization of structural aspects of biomolecules such as proteins
Purification, formulation, and analysis of protein therapeutics - Discovery and screening of protein biomarkers for cancer and other diseases.
- Cancer diagnostics is the focus of our subsidiary, Cleveland Diagnostics (formerly known as AnalizaDx, LLC)
our clients
large pharma and biotech
We're a functional service provider for some of the world's largest pharmaceutical companies, screening hundreds of compounds weekly.
Small to mid-size pharma and biotech
Our flexible service options make us a top choice for small to mid-size companies needing services that cannot be conducted internally.
academic and non-profit institutions
Our pricing makes us an affordable option for non-profit and academic institutions needing services that cannot be conducted internally.
contract research services
High-quality, gold-standard assays for accurate determination of physchem parameters, including logD, solubility, and other information critical for understanding the interaction between the body and a drug candidate. We also pioneered fast, accurate measurements of physicochemical parameters such as solubility to provide key interpretation data obtained from in vitro biological assays, including safety assays such as ion channel screens. Our data are measured using patented, innovative robotic platforms that enable high-throughput, low-cost, and highly accurate results that mean the same throughout the drug discovery and development process.
Development of innovative simple assays for characterization of the structure of biomolecules, in particular of protein products and therapeutics. We invented techniques and instruments to provide answers to difficult questions related to changes in the higher-order structure of such products, enabling fingerprint (signature)-like assays that can be calibrated for many important tasks in quality control, characterization, lot release, and biosimilarity of proteins.
Development of custom solutions for large-scale protein purification processing using aqueous two-phase partitioning. These solutions enable low cost processing of large amounts of biological materials, separating the protein product from plant, cell, or bacteria matter, and are typically deployed before chromatographic purification steps.